Barclays maintains Manhattan Associates at Overweight, raises price target to $275 from $239
Barclays reaffirmed its Overweight rating on Manhattan Associates and increased its price target to $275 from $239, suggesting a 10.7% upside from the last close. Recent analyst targets for the company range from $230 to $305.
How this was made

The 30-second read
Why it matters
The price target increase could prompt short covering and new buying, modestly boosting the stock.
Market read
Analyst target upgrades are a common catalyst for short‑term price moves in mid‑cap tech stocks.
What to watch
Potential execution risks in the company's growth initiatives are not addressed by the target change.
Background
Barclays' analyst note updates its valuation model for Manhattan Associates, reflecting recent operational improvements.
Ticker impact
Barclays raised its price target on Manhattan Associates to $275 from $239, indicating a bullish outlook.
likely upward pressure as investors price in the higher target
The 15% target increase signals confidence in future performance, which can attract buying interest.
Market effects
May lift sentiment for the broader supply‑chain software sector.
Primarily U.S. equity market impact.
Limited to investors tracking Manhattan Associates and related tech stocks.
Counterpoint
Some investors may view the target raise as already priced in and wait for concrete earnings beat.
Key entities
- companyManhattan Associates
Supply‑chain software provider.
- financial_institutionBarclays
Equity research firm issuing the target raise.


